Postmarketing Drug Safety Compliance: 2019 Inspection Findings
45:13
Conducting Clinical Trials During the COVID-19 Public Health Emergency
17:02
CDER BIMO: Electronic Submission Requirements for New Drug and Biologic Licensing Applications
1:42:25
FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session Two
41:59
National Drug Code (NDC) for Healthcare Providers
1:47:20
FDA Clinical Investigator Training Course (CITC) 2024 – Day Three – Session Two
2:14:51
FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One
1:43:17
FDA Clinical Investigator Training Course (CITC) 2024 – Day Three – Session One
7:49:20